An expanded approval of abiraterone acetate (Zytiga) to treat metastatic castration-resistant prostate cancer prior to chemotherapy. ... The drug was initially approved in November 2011 for use in patients whose prostate cancer progressed after treatment
Preventive Services Task Force finding that prostate-specific antigen (PSA) screening for prostate cancer does more harm than good, the most frequent response I hear from physicians who continue to defend ... That's pretty much what we do by deploying
But it turns out that diagnosing prostate cancer sooner hurts more than it helps. ... Prostate cancer frequently takes a decade or longer before it causes patients any harm.
Cabazitaxel (Jevtana), a chemotherapy drug used with prednisone for prostate cancer. ... It is the first treatment for advanced, hormone-refractory prostate cancer that has worsened during or after treatment with docetaxel.
An Annals of Internal Medicine editorial in the May 5 issue again notes that, “Within 10 years of trial entry, screening increases the number of cancer cases diagnosed but has no ... by overzealous therapies and like to pronounce themselves as
Watchful waiting" has been most discussed as a treatment strategy for prostate cancer. ... Treatment for prostate cancer, including radical prostatectomy, is fraught with side effects that may negatively impact quality of life.
Sipuleucel-T (Provenge), autologous cellular immunotherapy approved to treat asymptomatic or minimally symptomatic prostate cancer that has spread to other parts of the body and is resistant to standard hormone treatment. ... cancer. Most of the studies
For example, several days ago the United States Preventive Services Task Force (USPSTF) came out with its final guideline on using PSA for the purpose of screening for prostate cancer. ... I discuss the debate more in my previous post: Should Doctors
Cheatham. Another etiology of rectal bleeding is radiation proctitis, which typically develops one to two years after radiation exposure in those treated for cervical cancer or prostate cancer, he noted. ... Cheatham. Finally, he said, cancer is an
Given that many patients with prostate cancer have normal PSAs and lots of patients with high PSAs don't have prostate cancer, it doesn't seem semantically correct to call it ... prostate cancer screening".) Surprise!